Avata Biosciences
PrivateLast Round
Strategic
Jun 17, 2025
Total Funding Raised
$95M
Company Overview
Avata Biosciences operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Strategic round in June 2025.
Avata Biosciences is a biopharmaceutical company that develops synthetic cannabinoid-based medicines for the treatment of neurological diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avata Biosciences Comparables
Compare Avata Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Jazz Pharmaceuticals | 71% | |
| Harmony Biosciences Holdings, Inc. | 69% | |
| Ananda Pharma plc | 68% |
For institutional investors. Book with your work email.
Avata Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jun 17, 2025 | ||||
| VC Round | May 13, 2024 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 2, 2026
Monthly visitors increased 171% MoM.
- May 13, 2024
$110M raised in a VC Round.
For institutional investors. Book with your work email.
Avata Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Avata Biosciences's valuation, stock price, and market status.
Is Avata Biosciences a public or private company?
Avata Biosciences is a private company.
What is the current stock price of Avata Biosciences?
Avata Biosciences is a private company, so its shares have no public market price. Caplight tracks Avata Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Avata Biosciences worth (valuation)?
Valuation information for Avata Biosciences is not publicly available.
Can I buy Avata Biosciences stock?
Avata Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Avata Biosciences's last funding round?
Avata Biosciences's most recent funding round was Strategic on June 17, 2025.
Who are the main investors in Avata Biosciences?
Investor information for Avata Biosciences is not publicly disclosed.
Will Avata Biosciences IPO soon?
No public IPO plans have been announced for Avata Biosciences.
How can I track Avata Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Avata Biosciences's shares on secondary markets.